✦ LIBER ✦

Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance

✍ Scribed by Louis J. Aronne; Nick Finer; Priscilla A. Hollander; Richard D. England; Solomon S. Klioze; Robert D. Chew; Robert J. Fountaine; Coralie M. Powell; John D. Obourn

Book ID: 109970230
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 325 KB
Volume: 19
Category: Article
ISSN: 1930-7381
DOI: 10.1038/oby.2010.352

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo pharmacology of CP-

In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity

✍ John R. Hadcock; David A. Griffith; Phillip A. Iredale; Phillip A. Carpino; Robe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Discovery of 1-[9-(4-Chlorophenyl)-8-(2-

Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9 H -purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist

✍ Griffith, David A.; Hadcock, John R.; Black, Shawn C.; Iredale, Philip A.; Carpi 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 145 KB

P.5.023 The effects of cannabinoid CB1 r

P.5.023 The effects of cannabinoid CB1 receptor antagonist AM 251 on locomotor/exploratory behaviour and body weight in mice

✍ K. Slais; L. Landa; A. Sulcova 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB